$156.08 0.97 (0.62%)
8:27 EST ZTS Stock Quote Delayed 30 Minutes
Previous Close -
Market Cap 75.52B
PE Ratio 78.43
Volume (Avg. Vol.) 245
Day's Range 157.05 - 157.05
52-Week Range 90.14 - 176.64
Dividend & Yield 0.38 (0.24%)
ZTS Stock Predictions, Articles, and Zoetis News
- From InvestorPlace
- From the Web
When it comes to stocks to buy, we are getting more selective, and that’s a good thing. In fact, buying pressure in more selective stocks means they may have more profit potential going forward.
These are some of the top stocks to buy if you want to make a play on the growth and strength of the Chinese economy.
Americans love their pets, and no pandemic, not even the novel coronavirus, will change that, bolstering these eight pet stocks.
True, there are political risks in the industry. But there are also lots of growth opportunities for investors in healthcare stocks.
More households own pets than have children, and they'll pay to keep their furry friends happy. Here are 6 big pet stocks.
Pharmaceutical stocks help make the world go round. Without them, common ailments would plague our lives. With them, we can solve Covid-19.
These seven healthcare stocks may represent robust long-term investments no matter how reforms in the sector may develop post-election.
Chewy, Zoetis and FreshPet are just a couple of the names on our list of pet stocks to buy. Let's look at this growing industry more closely.
Zoetis (NYSE:ZTS), a class-leading animal health and vaccine company, including animal-to-human virus vaccines, used to be a subsidiary of pharmaceutical giant Pfizer (NYSE:PFE), but it spun off in 2013.
A handful of pharmaceutical stocks have been on fire lately, but I'm writing for a "buy" prescription for five of the best names now.
The pandemic isn't the only reason you should be looking a pharmaceutical stocks. Here are six pharma companies that stand out with or without Covid-19.
These are three of best pet stocks to buy now. Each is riding the recent wave of pet ownership due to the novel coronavirus.
Environmental, Social and Governance investing may seem counter to maximizing profits, but the best ESG stocks deliver for all stakeholders.
There’s a select group of pharmaceutical stocks that stand to win without even looking for a Covid-19 cure.
Global pet care sales could hit $203 billion by 2025. Here are seven pet care stocks to buy from the only pet care ETF in the U.S.
Much of the conversation about pharmaceutical stocks rests on the coronavirus, but these high-growth names have potential beyond the pandemic.
Navellier RatingsPowered by Portfolio Grader